Abstract
Group B streptococcus (GBS), also known as Streptococcus agalactiae, is the leading cause of neonatal morbidity and mortality in the United States. Early-onset GBS disease (EOGBS) in newborns occurs within the first week of life. Clinical syndromes associated with EOGBS include meningitis, pneumonia, and sepsis, which can ultimately lead to death.